🇺🇸 SFC in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Activities Of Daily Living Impaired — 1 report (10%)
2. Asthma — 1 report (10%)
3. Body Temperature Decreased — 1 report (10%)
4. Catheter Thrombosis — 1 report (10%)
5. Central Obesity — 1 report (10%)
6. Cerebral Haemorrhage — 1 report (10%)
7. Decreased Appetite — 1 report (10%)
8. Deep Vein Thrombosis — 1 report (10%)
9. Disseminated Cryptococcosis — 1 report (10%)
10. Disseminated Intravascular Coagulation — 1 report (10%)

Source database →

Frequently asked questions

Is SFC approved in United States?

SFC does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for SFC in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.